Sunday, November 1, 2026

SpaceX Futures Trading Soars: How Binance and OKX Are Changing the Game

SpaceX's NASDAQ debut fuels strong trading interest, with over $1.32 billion in daily futures trading on crypto exchanges since listing.

The Loneliest Cry: North Korea Walks Alone Into Winter, Desperate To Prove It Still Exists

North Korea's Rodong Sinmun highlights Kim Jong Un's Mount Paektu ride, reinforcing his legitimacy amid year-end political maneuvers.

Daewon Pharmaceutical’s DW5324: A Game-Changer in Diabetes Treatment with 3.14x Drug Exposure

Daewon Pharmaceutical's oral drug delivery platform shows up to 3.14 times higher drug exposure in diabetes and obesity treatments.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.

How AI is Revolutionizing Drug Development: Insights from BIO International Convention 2026

The 2026 BIO International Convention focuses on AI, shifting from technology introduction to validating business outcomes.

Dong-A ST Eyes Early-Stage Licensing Deals as Key Growth Strategy, Says VP Oh Yoon-seok [BIO USA]

Dong-A ST aims for global expansion by licensing preclinical drug candidates, focusing on timely execution of R&D strategies by 2027.

Alteogen CEO Says Additional Licensing Deals Near Completion, Highlights Patent Strength [BIO USA]

Alteogen is nearing global licensing deals, focusing on maximizing value and expanding its platform technology in biopharma.

SK Biopharm CEO Lee Dong-hoon: “AI and open innovation are key to drug development” [BIO USA]

SK Biopharmaceuticals focuses on open innovation and AI for drug development, aiming to enhance CNS therapies and expand into new modalities.

Supply Chains, M&A and AI: As China Closes In, K-Bio Faces a Critical Window of Opportunity [BIO USA]

Korea's biotech industry faces challenges and opportunities amid global restructuring, emphasizing AI and support for startups at BIO USA 2026.

BIO International Convention 2026: How K-Bio is Shaping the Global Bioindustry

The BIO International Convention 2026 in San Diego showcases biotech innovation, with a focus on AI integration and global partnerships.

How Samsung’s Galaxy Watch and Alcedis are Revolutionizing Clinical Research with Real-World Data

Samsung Electronics partners with Alcedis to use Galaxy Watch data for drug development, enhancing clinical trials with wearable tech.

Understanding Vocal Polyps: Causes, Symptoms, and Treatment Options for 2026

A lecturer suffered vocal cord polyps due to excessive voice use. Symptoms include hoarseness and difficulty speaking. Treatment varies.

9-Year-Old Siamese Cat’s Life-Saving Surgery: How a Massive Tumor Was Successfully Removed

A 9-year-old cat named Tini underwent successful surgery to remove a massive stomach tumor, now recovering with chemotherapy.

Mexico Recognizes South Korea’s MFDS: What This Means for Drug Approvals

Mexico recognizes South Korea's MFDS as a reference authority, streamlining drug approvals and enhancing market access for Korean firms.

3 Alarming Health Risks for 30-Somethings: How Prehypertension and Prediabetes Can Double Your Stroke Risk

A study reveals that young adults with prehypertension, prediabetes, and borderline dyslipidemia face increased heart attack and stroke risks.

PharmaResearch says AMWC appearance validates its standing as a global medical aesthetics company

PharmaResearch showcased its Rejuran aesthetic solutions at AMWC Korea 2026, winning an award and gaining global recognition in aesthetic medicine.

Drug Development Is Inherently Unprofitable, Biotech Industry Warns as Delisting Reform Looms

South Korea's biotech sector faces stricter delisting rules, raising concerns over innovation and funding for drug development.

New Hope for IPF Patients: How Jascayd is Revolutionizing Treatment in 2026

Jascayd offers new hope for idiopathic pulmonary fibrosis patients, slowing lung function decline with a novel mechanism of action.

Top News

- Our Sponsors Ad -

Follow us